Schott’s Pharmaceutical Packaging business inaugurated production of ready-to-fill glass syringes this week at its manufacturing facility in Lebanon, PA. Production capacity at the 170,000 square foot plant will be 270,000 units per day, with Schott moving to round-the-clock production in the next two years.
“We hope to increase the market share of domestically produced ready-to-fills once we are fully operational here in Lebanon,” said Renard Jackson, vice president of Schott North America, Inc., and general manager, Pharmaceutical Packaging division.
“We are delivering the same high quality standards our customers have come to expect,” he added.
The production line incorporates the most advanced techniques including dimensional camera inspection and clean room final packaging in conforming with FDA cGMP standards for products and production processes.
Schott first launched its United States operations in Duryea, PA in 1992. With the new production capacity at Lebanon, all of the firm’s portfolio of pharmaceutical packaging products including vials, ampules, and cartridges will be produced in North America.
The $14 million-plus investment for pre-filled syringe production will create about 40 new jobs over the next year. Long-term plans for the Lebanon facility include further investment in excess of $30 million and incremental employment of 80, the company said.